A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

Tennessee's Medicaid program, TennCare, covers drugs like Ozempic and Mounjaro to treat those with diabetes and heart ...

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Kennedy has promised to "Make America Healthy Again" by tackling obesity with nutrition. Here's how he could rattle the ...

Join the debate on weight loss drugs at NAILBA 43. Experts discuss the risk factors and effectiveness of GLP-1 drugs like Ozempic.

The Ipsos survey of 1,078 adults found 24 of people would use weight-loss jabs if they were provided for free by the health service.

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

The use of diabetes and weight-loss medications like Ozempic or Wegovy—called GLP-1 drugs—has exploded in recent years, with ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

TennCare – the state Medicaid program that pays the medical bills of 1.4 million low-income Tennesseans – is seeking a $975 ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...